| dc.contributor.author | Korman, Max | |
| dc.contributor.author | Retterstøl, Kjetil | |
| dc.contributor.author | Kristiansen, Ivar Sønbø | |
| dc.contributor.author | Wisløff, Torbjørn | |
| dc.date.accessioned | 2022-07-25T13:17:49Z | |
| dc.date.available | 2022-07-25T13:17:49Z | |
| dc.date.created | 2018-07-03T10:44:24Z | |
| dc.date.issued | 2018 | |
| dc.identifier.citation | PharmacoEconomics (Auckland). 2018, 36 (9), 1031-1041. | |
| dc.identifier.issn | 1170-7690 | |
| dc.identifier.uri | https://hdl.handle.net/11250/3008266 | |
| dc.language.iso | eng | |
| dc.title | Are PCSK9 Inhibitors Cost Effective? | |
| dc.type | Peer reviewed | |
| dc.type | Journal article | |
| dc.description.version | publishedVersion | |
| dc.description.version | acceptedVersion | |
| dc.description.version | submittedVersion | |
| dc.source.pagenumber | 1031-1041 | |
| dc.source.volume | 36 | |
| dc.source.journal | PharmacoEconomics (Auckland) | |
| dc.source.issue | 9 | |
| dc.identifier.doi | 10.1007/s40273-018-0671-0 | |
| dc.identifier.cristin | 1595369 | |
| cristin.unitcode | 7502,4,19,0 | |
| cristin.unitname | Avdeling for infeksjonsepidemiologi og modellering | |
| cristin.ispublished | true | |
| cristin.fulltext | original | |
| cristin.fulltext | postprint | |
| cristin.fulltext | preprint | |
| cristin.qualitycode | 2 | |
